Clinical Trial Update: A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules

View source ↗

Summary

Clinical trial evaluating pregnancy outcomes in females treated with elagolix has been terminated. The study, sponsored by AbbVie, targeted endometriosis and ut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Uterine Fibroids

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Endometriosis, Uterine Fibrioids | Status: TERMINATED